1. Pan, Yuanwang, Han, Han, Hu, Hai, Zhang, Hua, Wong, Kwok-Kin. 2022. KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. In Cancer cell, 41, 88-105.e8. doi:10.1016/j.ccell.2022.11.015. https://pubmed.ncbi.nlm.nih.gov/36525973/
2. Froimchuk, Eugene, Jang, Younghoon, Ge, Kai. 2017. Histone H3 lysine 4 methyltransferase KMT2D. In Gene, 627, 337-342. doi:10.1016/j.gene.2017.06.056. https://pubmed.ncbi.nlm.nih.gov/28669924/
3. Boniel, Snir, Szymańska, Krystyna, Śmigiel, Robert, Szczałuba, Krzysztof. 2021. Kabuki Syndrome-Clinical Review with Molecular Aspects. In Genes, 12, . doi:10.3390/genes12040468. https://pubmed.ncbi.nlm.nih.gov/33805950/
4. Xu, Jing, Zhong, Ailing, Zhang, Shan, Liu, Yu, Niu, Ting. 2023. KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2206098. doi:10.1002/advs.202206098. https://pubmed.ncbi.nlm.nih.gov/37142882/
5. Kubo, Naoki, Chen, Poshen B, Hu, Rong, Sasaki, Hiroyuki, Ren, Bing. 2024. H3K4me1 facilitates promoter-enhancer interactions and gene activation during embryonic stem cell differentiation. In Molecular cell, 84, 1742-1752.e5. doi:10.1016/j.molcel.2024.02.030. https://pubmed.ncbi.nlm.nih.gov/38513661/
6. Li, Jie, Chin, Christopher R, Ying, Hsia-Yuan, Béguelin, Wendy, Melnick, Ari M. 2024. Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment. In Nature communications, 15, 2879. doi:10.1038/s41467-024-47012-1. https://pubmed.ncbi.nlm.nih.gov/38570506/
7. Tran, Nhien, Broun, Aaron, Ge, Kai. 2020. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer. In Molecular and cellular biology, 40, . doi:10.1128/MCB.00341-20. https://pubmed.ncbi.nlm.nih.gov/32817139/
智鼠故事 
